Navigation Links
Device zeroes in on small breast tumors
Date:1/28/2008

A new medical imager for detecting and guiding the biopsy of suspicious breast cancer lesions is capable of spotting tumors that are half the size of the smallest ones detected by standard imaging systems, according to a new study.

The results of initial testing of the PEM/PET system, designed and constructed by scientists at the Department of Energys Thomas Jefferson National Accelerator Facility, West Virginia University School of Medicine and the University of Maryland School of Medicine will be published in the journal Physics in Medicine and Biology on Feb. 7.

This is the most-important and most-difficult imager weve developed so far, Stan Majewski, Jefferson Lab Radiation Detector and Medical Imaging Group leader said. It is another example of nuclear physics detector technology that we have put a lot of time and effort into adapting for the common good.

Testing of the new imager was led by Ray Raylman, a professor of radiology and vice chair of Radiology Research at WVU and lead author on the study. Raylmans team imaged various radioactive sources to test the resolution of the system.

We had good performance characteristics, with image resolution below two millimeters. In regular PET, the image resolution is over five millimeters, so we're quite a bit better than that, Raylman said. In addition, the initial tests revealed that the PEM/PET system can complete an image and biopsy in about the same amount of time as a traditional biopsy.

The ability of the device to do biopsy is probably one of its most unique characteristics. There are other breast imagers, but none that are built specifically to do biopsy as well as imaging, Raylman said.

The system features components designed for imaging the unique contours of the breast. Known as positron emission mammography (PEM), this imaging capability enables users to attain high-resolution, three-dimensional PET images of the breast. The PEM/PET system images the breast with a movable array of two pairs of two flat detection heads.

If a suspected lesion is found, a single pair of heads is then used to guide a needle biopsy of the lesion; the biopsy is performed with a person-controlled robot arm. Raylman is the author of the concept and has a patent on this idea. The system is especially useful in imaging tumors in women who have indeterminate mammograms because of dense or fibroglandular breasts.

The Jefferson Lab Radiation Detector and Medical Imaging Group, with a group member now affiliated with the University of Maryland School of Medicine, developed the detector heads with the on-board electronics, the data acquisition readout and the image reconstruction software. The imaging devices gantry and the motion-control software was developed by West Virginia University researchers.

The next steps for the team include minor improvements in the detector systems and image reconstruction software and the addition of components for taking x-ray computed tomography (CT) scans. Initial clinical trials are planned after completion of system testing.


'/>"/>

Contact: Kandice Carter
kcarter@jlab.org
757-269-7263
DOE/Thomas Jefferson National Accelerator Facility
Source:Eurekalert

Related medicine news :

1. MSU engineering team designs innovative medical device
2. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
3. Implantable device designed to detect, stop seizures under study at MCG
4. Visiprise Launches Podcast Series with AMR to Support Medical Device Manufacturers
5. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
6. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
7. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
8. Mobility-enhancing device developed at University of Alberta will receive prestigious da Vinci Award
9. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
10. FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
11. FDA approves knee-injury device for humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... May 28, 2016 , ... SuperCloset is proud to officially launch our ... to day issues, struggles and obstacles veterans’ need to overcome in order to face ... active or retired military veteran(s) with a donated SuperCloset product based on the needs ...
(Date:5/28/2016)... ... ... After a year and a half of planning the Multiple Pathways of Recovery Conference ... of Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel ... to explore the many pathways individuals use to get into and sustain their recovery. ...
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses and ... to shed lights on the variety of topics detailing why we appreciate nurses in ... why this career has gone from being in a major recession to one of ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... caregivers to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy ... trends and tech within the industry, from leading advocates, associations and industry leaders ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... KONG , May 24, 2016 ... , the world , s first ... AV fistula intervention   OrbusNeich, a global ... has expanded its portfolio to include products to treat ... are the company,s first entry devices for lower limb ...
Breaking Medicine Technology: